NIH PAR · NIDA · R34

PAR-28-093: Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 26, 2026Editorial standards

Opens Jan 16, 2027Next due date: Feb 16, 2027Expires Jul 17, 2029

The purpose of this notice of funding opportunity (NOFO) is to support pilot and feasibility studies to inform the design and conduct of efficacy, effectiveness, and/or services research trials. Topics may include: 1) developing interventions to prevent substance use, misuse, or progression to substance use disorder; 2) prevention, treatment, or recovery services research, including research addressing comorbid pain and medical and mental health disorders; and 3) HIV eradication research, including implementation science, prevention, treatment and recovery in substance use settings/populations.

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-28-093
Type
PAR
Activity code
R34
Primary institute
NIDA · National Institute on Drug Abuse
Clinical trials
Optional
Posted
Oct 19, 2026
Opens
Jan 16, 2027
Expires
Jul 17, 2029

PAR-28-093 due dates

8 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-28-093
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
February 16, 2027 *March 16, 2027 *Not ApplicableJuly 2027October 2027December 2027
June 16, 2027 *July 16, 2027 *Not ApplicableNovember 2027January 2028April 2028
October 16, 2027 *November 16, 2027 *Not ApplicableMarch 2028May 2028July 2028
February 16, 2028 *March 16, 2028 *Not ApplicableJuly 2028October 2028December 2028
June 16, 2028 *July 16, 2028 *Not ApplicableNovember 2028January 2029April 2029
October 16, 2028 *November 16, 2028 *Not ApplicableMarch 2029May 2029July 2029
February 16, 2029 *March 16, 2029 *Not ApplicableJuly 2029October 2029December 2029
June 16, 2029 *July 16, 2029 *Not ApplicableNovember 2029January 2030April 2030

What its predecessor PAR-24-060 funded

PAR-28-093 reissues PAR-24-060. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 9 projects and $5.7M in FY2022–FY2026.

Projects funded

9

Distinct projects, FY2022–FY2026

New awards

9

Type 1 (new project) award records

NIH funding

$5.7M

Award dollars under PAR-24-060, FY2022–FY2026

Funding by fiscal year

Award records, new awards, and funding by fiscal year under PAR-24-060
Fiscal yearAward recordsNew awardsFunding
FY202200$0
FY202300$0
FY202411$668K
FY202533$1.8M
FY202665$3.3M

Institutions with the most funding

  1. Yale University$770K · 1 project
  2. Brown University$710K · 1 project
  3. University of Washington$671K · 1 project
  4. Washington State University$668K · 1 project
  5. University of New Mexico$651K · 1 project

Funding institutes

  • NIAAA$3.0M · 5
  • NIDA$2.7M · 5

Activity codes funded

  • R3410 records

FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.

Participating institutes

3 NIH institutes and offices take applications under PAR-28-093. Contact the program officer at the institute that fits your research before applying.

  • NIDA · National Institute on Drug Abuse
  • OAR
  • ODP

Related notices

NIH lists no related notices for PAR-28-093 yet.

Award terms

Application types allowed
New Resubmission Revision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
Award budget
Applicants may request direct costs of up to 450,000 for three years. Although variations from year to year are permissible, in no case may any year be more than 225,000 in direct costs, and total direct costs for the entire project period may not exceed 450,000.
Project period
The maximum project period is three years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
Funds available and number of awards
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

Related NOFOs

  • Reissue of PAR-24-060.

Other open NOFOs for R34

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. NIH Guide data refreshed October 26, 2026, RePORTER funding October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO